Autori: Matytsina Irina
| Naslov | Body Mass Index Best Predicts Recovery of Recombinant Factor VIII in Underweight to Obese Patients with Severe Haemophilia A (Article) |
| Autori | Tiede Andreas Rosa Cid Ana Goldmann Georg Jimenez-Yuste Victor Pluta Michael Lissitchkov Toshko May Marcus Matytsina Irina Miljic Predrag S Pabinger Ingrid Persson Paula |
| Info | THROMBOSIS AND HAEMOSTASIS, (2020), vol. 120 br. 2, str. 277-288 |
| Projekat | Novo Nordisk A/S (Bagsvaerd, Denmark)Novo Nordisk |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | A New Dosing Model Based on Body Mass Index to Guide Factor VIII Dosing in Patients with Hemophilia A (Meeting Abstract) |
| Autori | Tiede Andreas Goldmann Georg Miljic Predrag S Korsholm Lars Matytsina Irina Persson Paula Jelev Lissitchkov Toshko |
| Info | BLOOD, (2018), vol. 132 br. , Suppl. 1, str. - |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Long-term safety and efficacy of turoctocog alfa in prophylaxis and treatment of bleeding episodes in severe haemophilia A: Final results from the guardian 2 extension trial (Article) |
| Autori | Lentz Steven R Janic Dragana M Kavakli Kaan Miljic Predrag S Oldenburg Johannes Ozelo Margareth Castro Santagostino Elena Suzuki Takashi Zupancic-Salek Silva Korsholm Lars Matytsina Irina Tiede Andreas |
| Info | HAEMOPHILIA, (2018), vol. 24 br. 6, str. E391-E394 |
| Projekat | Novo Nordisk A/S |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Use of turoctocog alfa for less-frequent prophylaxis in selected patients has comparable efficacy with the overall prophylaxis cohort in Guardian (TM) 2 (Meeting Abstract) |
| Autori | Tiede Andreas Janic Dragana M Ozelo M Santagostino E Korsholm Lars Matytsina Irina Lentz SR |
| Info | HAEMOPHILIA, (2018), vol. 24 br. , Suppl. S1, str. 52-52 |
| Projekat | Alnylam; Baxter/Baxalta/Shire; Bayer; Biogen Idec; Biotest; CSL Behring; Novo Nordisk A/S; Octapharma; Pfizer; Roche; Sobi; Baxter; Shire |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Spontaneous Bleeding Rate On Turoctocog Alfa Prophylaxis in a Large Cohort of Patients With Haemophilia A Followed For up to 5 Years - Trends Over Time and Across Geography (Meeting Abstract) |
| Autori | Santagostino E Martin Salces M Lejniece Sandra Janic Dragana M Tripkovic N Matytsina Irina |
| Info | HAEMOPHILIA, (2017), vol. 23 br. , Suppl. S2, str. 56-57 |
| Projekat | Pfizer; Baxter; Bayer; Novo Nordisk; Octopharma |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Interim results from a large multinational extension trial (guardian (TM) 2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A (Letter) |
| Autori | Lentz SR Cerqueira MH Janic Dragana M Kempton CL Matytsina Irina Misgav M Oldenburg J Ozelo M Recht M Rosholm A Savic Aleksandar D Suzuki Takashi Tiede Andreas Santagostino E |
| Info | HAEMOPHILIA, (2016), vol. 22 br. 5, str. E445-E449 |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Efficacy and safety of turoctocog alfa for prophylaxis and treatment of bleeding episodes in patients with severe hemophilia A: results from the guardian (TM) 2 trial (Meeting Abstract) |
| Autori | Janic Dragana M Karim Faraizah Abdul Matytsina Irina Ozelo Margareth Castro Savic Aleksandar D Tiede Andreas Oldenburg Johannes |
| Info | HAEMOPHILIA, (2016), vol. 22 br. , Suppl. 4, str. 48-48 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Changes in Annualized Bleeding Rate Over Time and Relationship with Dosing of Tutoctocog a During the Guardian Program (Meeting Abstract) |
| Autori | Mancuso ME Ozelo M Janic Dragana M Matytsina Irina Landorph Andrea Zeuthan Niels Roveda A Pellegrino G |
| Info | HAEMATOLOGICA, (2015), vol. 100 br. , Suppl. 3, str. 65-66 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Interim results from a large multinational extension trial (Guardian TM2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A (Meeting Abstract) |
| Autori | Lentz SR Kempton CL Janic Dragana M Savic Aleksandar D Cerqueira MH Ozelo MC Recht M Oldenburg J Tiede Andreas Suzuki Takashi Matytsina Irina Zeuthen N Santagostino E |
| Info | JOURNAL OF THROMBOSIS AND HAEMOSTASIS, (2015), vol. 13 br. , Suppl. 2, str. 842-842 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Prior Treatment Regimen Influences Annualised Bleeding Rate During Long- Term Prophylaxis With Turoctocog Alfa: Experiences From Multinational Trials (Meeting Abstract) |
| Autori | Laguna P Savic Aleksandar D Matytsina Irina Zeuthen N |
| Info | HAEMOPHILIA, (2015), vol. 21 br. , Suppl. 2, str. 49-49 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
